{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 1871, "pageSize": 18, "pageCount": 17777, "rows": [ { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 13, "slideType": "timeline", "function": "present_framework", "notes": "Includes a funnel-style chart for development phases and a timeline chart for Phase III candidates.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/13", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-13", "loopMatches": [ { "to": 14, "from": 9, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "019dd95a-088c-724c-b30f-be0320e082a4", "evidence": "p11-12 frame unprecedented response and 12-18 month window; p13-14 detail fast movers and Q2 2021 distribution.", "position": 3, "objective": "Establish unprecedented vaccine response and timeline opportunity", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 75, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 17, "from": 9, "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors", "position": 3, "confidence": 78, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 14, "from": 4, "beatId": "019dd95a-0702-74a3-87e3-b9ab3fe072a9", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Facts (What)", "beatSlug": "triple-take-the-facts-what", "evidence": "Snapshot, epidemic curves, vaccine pipeline, timelines", "position": 1, "confidence": 65, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 14, "slideType": "timeline", "function": "plan_implementation", "notes": "Includes a detailed legend/note section at the bottom regarding data sources and assumptions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/14", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-14", "loopMatches": [ { "to": 14, "from": 9, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "019dd95a-088c-724c-b30f-be0320e082a4", "evidence": "p11-12 frame unprecedented response and 12-18 month window; p13-14 detail fast movers and Q2 2021 distribution.", "position": 3, "objective": "Establish unprecedented vaccine response and timeline opportunity", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 75, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 17, "from": 9, "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors", "position": 3, "confidence": 78, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 14, "from": 4, "beatId": "019dd95a-0702-74a3-87e3-b9ab3fe072a9", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Facts (What)", "beatSlug": "triple-take-the-facts-what", "evidence": "Snapshot, epidemic curves, vaccine pipeline, timelines", "position": 1, "confidence": 65, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a three-column layout to compare key metrics for vaccine success.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/15", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-15", "loopMatches": [ { "to": 16, "from": 15, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "019dd95a-088c-724c-b30f-c34ed2dbf344", "evidence": "p15 lists efficacy/safety/immunity factors; p16 cascades into immediate priorities by efficacy band.", "position": 4, "objective": "Translate three vaccine success factors into priority actions by efficacy outcome", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 78, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 17, "from": 9, "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors", "position": 3, "confidence": 78, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 19, "from": 15, "beatId": "019dd95a-0702-74a3-87e3-bed022269a97", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Implications (So What)", "beatSlug": "triple-take-the-implications-so-what", "evidence": "Key success factors, efficacy priorities, scenarios", "position": 2, "confidence": 65, "parentBeatName": "Reflection", "parentBeatSlug": "reflection" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 16, "slideType": "initiative_list", "function": "prioritize", "notes": "Includes a quote from Dr. Peter Marks regarding herd immunity and vaccine efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/16", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-16", "loopMatches": [ { "to": 16, "from": 15, "name": "So What Cascade", "slug": "41-so-what-cascade", "bestFor": "Data presentations, executive summaries, driving to recommendations", "matchId": "019dd95a-088c-724c-b30f-c34ed2dbf344", "evidence": "p15 lists efficacy/safety/immunity factors; p16 cascades into immediate priorities by efficacy band.", "position": 4, "objective": "Translate three vaccine success factors into priority actions by efficacy outcome", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "confidence": 78, "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion" } ], "arcBeatMatches": [ { "to": 17, "from": 9, "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors", "position": 3, "confidence": 78, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 19, "from": 15, "beatId": "019dd95a-0702-74a3-87e3-bed022269a97", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Implications (So What)", "beatSlug": "triple-take-the-implications-so-what", "evidence": "Key success factors, efficacy priorities, scenarios", "position": 2, "confidence": 65, "parentBeatName": "Reflection", "parentBeatSlug": "reflection" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 17, "slideType": "industry_trends", "function": "analyze_data", "notes": "The slide uses a stacked bar chart to show production capacity split by end of 2020 and end of 2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/17", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-17", "loopMatches": [ { "to": 19, "from": 17, "name": "Scenario Fork", "slug": "35-scenario-fork", "bestFor": "Strategic planning, risk analysis, board presentations", "matchId": "019dd95a-088c-724c-b30f-c66c12b1ec8c", "evidence": "p19 plots Scenario X/1/2/3 grid; p17-18 feed the inputs.", "position": 5, "objective": "Show manufacturing readiness, therapeutics, and scenario implications for leaders", "structure": "The Decision Point -> Scenario A (If X) -> Scenario B (If Y) -> Scenario C (If Z) -> Recommendation", "confidence": 72, "description": "Present multiple futures based on different assumptions or decisions" } ], "arcBeatMatches": [ { "to": 17, "from": 9, "beatId": "019dd95a-0702-74a3-87e3-afd1671a9591", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Solution & Approach", "beatSlug": "consultants-gambit-solution-approach", "evidence": "Vaccines/therapeutics as path; timelines, fast movers, success factors", "position": 3, "confidence": 78, "parentBeatName": "Turn", "parentBeatSlug": "turn" }, { "to": 19, "from": 15, "beatId": "019dd95a-0702-74a3-87e3-bed022269a97", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Implications (So What)", "beatSlug": "triple-take-the-implications-so-what", "evidence": "Key success factors, efficacy priorities, scenarios", "position": 2, "confidence": 65, "parentBeatName": "Reflection", "parentBeatSlug": "reflection" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 18, "slideType": "data_table", "function": "analyze_data", "notes": "The slide includes a stacked bar chart showing 314 total treatments across 5 phases, and a comparison table for 4 drugs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/18", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-18", "loopMatches": [ { "to": 19, "from": 17, "name": "Scenario Fork", "slug": "35-scenario-fork", "bestFor": "Strategic planning, risk analysis, board presentations", "matchId": "019dd95a-088c-724c-b30f-c66c12b1ec8c", "evidence": "p19 plots Scenario X/1/2/3 grid; p17-18 feed the inputs.", "position": 5, "objective": "Show manufacturing readiness, therapeutics, and scenario implications for leaders", "structure": "The Decision Point -> Scenario A (If X) -> Scenario B (If Y) -> Scenario C (If Z) -> Recommendation", "confidence": 72, "description": "Present multiple futures based on different assumptions or decisions" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 19, "from": 15, "beatId": "019dd95a-0702-74a3-87e3-bed022269a97", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Implications (So What)", "beatSlug": "triple-take-the-implications-so-what", "evidence": "Key success factors, efficacy priorities, scenarios", "position": 2, "confidence": 65, "parentBeatName": "Reflection", "parentBeatSlug": "reflection" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 19, "slideType": "scenario_analysis", "function": "present_solution", "notes": "The slide uses a 2x2 matrix to visualize scenarios, though the axes are not explicitly labeled, they represent the interplay of the listed factors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/19", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-19", "loopMatches": [ { "to": 19, "from": 17, "name": "Scenario Fork", "slug": "35-scenario-fork", "bestFor": "Strategic planning, risk analysis, board presentations", "matchId": "019dd95a-088c-724c-b30f-c66c12b1ec8c", "evidence": "p19 plots Scenario X/1/2/3 grid; p17-18 feed the inputs.", "position": 5, "objective": "Show manufacturing readiness, therapeutics, and scenario implications for leaders", "structure": "The Decision Point -> Scenario A (If X) -> Scenario B (If Y) -> Scenario C (If Z) -> Recommendation", "confidence": 72, "description": "Present multiple futures based on different assumptions or decisions" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 19, "from": 15, "beatId": "019dd95a-0702-74a3-87e3-bed022269a97", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Implications (So What)", "beatSlug": "triple-take-the-implications-so-what", "evidence": "Key success factors, efficacy priorities, scenarios", "position": 2, "confidence": 65, "parentBeatName": "Reflection", "parentBeatSlug": "reflection" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/20", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 21, "slideType": "kpi_dashboard", "function": "analyze_data", "notes": "The slide uses a color-coded legend integrated into the table to map lines to countries.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/21", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-21", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 22, "slideType": "data_table", "function": "analyze_data", "notes": "The chart uses a range-based visualization to show forecast uncertainty for 2020 and 2021.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/22", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-22", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 23, "slideType": "industry_trends", "function": "analyze_data", "notes": "The slide uses a dual-chart layout to contrast UK furlough data (bar/line combo) with US unemployment data (line chart).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/23", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-23", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 24, "slideType": "industry_trends", "function": "analyze_data", "notes": "The slide uses Google COVID-19 Community Mobility Reports data to track mobility changes relative to a Jan-Feb 2020 baseline.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/24", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-24", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 25, "slideType": "industry_trends", "function": "analyze_data", "notes": "BCG Economic Recovery Pulse Check (ERPC). Data covers GER, FR, UK, ITA, SPA, US, BR, CN, JP.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/25", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-25", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 26, "slideType": "data_table", "function": "analyze_data", "notes": "The charts visualize the impact of COVID-19 lockdowns and subsequent recovery phases on manufacturing sentiment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/26", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-26", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 27, "slideType": "industry_trends", "function": "analyze_data", "notes": "The slide uses a color-coded bar chart system to represent performance relative to 2019, with vertical dashed lines indicating lockdown start and easing periods.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/27", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-27", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 28, "slideType": "data_table", "function": "analyze_data", "notes": "The slide uses a color-coded heatmap to visualize economic recovery across different geographies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/28", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-28", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 29, "slideType": "data_table", "function": "analyze_data", "notes": "The slide uses a color-coded heatmap to visualize sales performance trends across different retail sectors and geographies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/29", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-29", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019dd923-5de0-76bd-a169-83187257f35b", "docSlug": "5d146414b5cc38c9", "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors", "authorId": "BCG", "authorName": "BCG", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "landscape", "aspectRatio": 1.778, "pageNumber": 30, "slideType": "data_table", "function": "analyze_data", "notes": "The slide uses a heatmap-style table to visualize financial health metrics across sectors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/30", "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b", "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-30", "loopMatches": [ { "to": 30, "from": 21, "name": "Segmentation Split", "slug": "34-segmentation-split", "bestFor": "Customer analysis, market research, resource allocation", "matchId": "019dd95a-088c-724c-b30f-cbc5b2acf370", "evidence": "Slides anchored on de-averaged; sector/country splits across mobility, retail, PMI, TSR.", "position": 6, "objective": "De-averaged view: how recovery splits by country, sector, and category", "structure": "The Aggregate View -> Segment A Behavior -> Segment B Behavior -> The Insight in the Difference", "confidence": 82, "description": "Divide a whole into meaningful segments to reveal hidden patterns" } ], "arcBeatMatches": [ { "to": 30, "from": 18, "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector", "position": 4, "confidence": 78, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" }, { "to": 30, "from": 21, "beatId": "019dd95a-0702-74a3-87e3-c0089e981d55", "arcName": "The Triple Take", "arcSlug": "triple-take", "beatName": "The Action (Now What)", "beatSlug": "triple-take-the-action-now-what", "evidence": "De-averaged econ implications by sector/country to inform agenda", "position": 3, "confidence": 65, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }